Science Explorer Back to mapMap
Institution · Ballad Health

Most cited papers from Ballad Health

What are the most cited papers from Ballad Health?

The most cited paper from Ballad Health is "Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study" (Gregg W. Stone, Bernhard Witzenbichler, Giora Weisz et al., 2013), with 863 citations. Next come "Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention" (456) and "Nonculprit Plaques in Patients With Acute Coronary Syndromes Have More Vulnerable Features Compared With Those With Non–Acute Coronary Syndromes" (237).

Showing 50 of 61 papers. Every paper with more than 20 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study Gregg W. Stone, Bernhard Witzenbichler, Giora Weisz et al. · The Lancet 25 Jul 2013 863
2 Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention Philippe Généreux, Gennaro Giustino, Bernhard Witzenbichler et al. · Journal of the American College of Cardiology Open access 24 Aug 2015 456
3 Nonculprit Plaques in Patients With Acute Coronary Syndromes Have More Vulnerable Features Compared With Those With Non–Acute Coronary Syndromes Koji Kato, Taishi Yonetsu, Soo–Joong Kim et al. · Circulation Cardiovascular Imaging 8 Jun 2012 237
4 Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions John A. Laird, Peter A. Schneider, Michael R. Jaff et al. · Circulation Cardiovascular Interventions Open access Jun 2019 186
5 Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial Gregg W. Stone, Stephen G. Ellis, Tommaso Gori et al. · The Lancet 25 Sep 2018 142
6 Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents Philippe Généreux, Björn Redfors, Bernhard Witzenbichler et al. · International Journal of Cardiology 26 Dec 2016 131
7 SUPERB final 3‐year outcomes using interwoven nitinol biomimetic supera stent Lawrence A. Garcia, Kenneth Rosenfield, Christopher Metzger et al. · Catheterization and Cardiovascular Interventions 4 May 2017 124
8 Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease Ramon L. Varcoe et al. · New England Journal of Medicine 25 Oct 2023 120
9 A Randomized Trial of a Dedicated Bifurcation Stent Versus Provisional Stenting in the Treatment of Coronary Bifurcation Lesions Philippe Généreux et al. · Journal of the American College of Cardiology Open access Feb 2015 119
10 Carotid Artery Stenting Christopher J. White, Thomas G. Brott, William A. Gray et al. · Journal of the American College of Cardiology Open access Jul 2022 113
11 Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes Hélène Eltchaninoff, Éric Durand, Bogdan Borz et al. · American Heart Journal 4 Nov 2013 109
12 Plasma Amino Acids and Milk Protein Production by Cows Fed Rumen-Protected Methionine and Lysine John Allen Rogers, U. Krishnamoorthy, C.J. Sniffen · Journal of Dairy Science Open access Apr 1987 95
13 Stent Expansion Indexes to Predict Clinical Outcomes Tatsuhiro Fujimura, Mitsuaki Matsumura, Bernhard Witzenbichler et al. · JACC: Cardiovascular Interventions Open access Aug 2021 78
14 Prevalence, Features, and Prognostic Importance of Edge Dissection After Drug-Eluting Stent Implantation Nobuaki Kobayashi, Gary S. Mintz, Bernhard Witzenbichler et al. · Circulation Cardiovascular Interventions Open access Jul 2016 75
15 Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents Akiko Maehara, Gary S. Mintz, Bernhard Witzenbichler et al. · Circulation Cardiovascular Interventions Nov 2018 68
16 Pivotal Study of a Next-Generation Balloon-Expandable Stent-Graft for Treatment of Iliac Occlusive Disease Jean X. Bismuth, Bruce H. Gray, Andrew Hugh Holden et al. · Journal of Endovascular Therapy 12 Jul 2017 67
17 A Prediction Model to Identify Patients at High Risk for 30-Day Readmission After Percutaneous Coronary Intervention Jason H. Wasfy, Kenneth Rosenfield, Katya Zelevinsky et al. · Circulation Cardiovascular Quality and Outcomes Open access Jul 2013 66
18 5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique Gregg W. Stone, Dean J. Kereiakes, Tommaso Gori et al. · Journal of the American College of Cardiology Open access 17 May 2023 62
19 Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity Katherine Hsin-Yu Chau, Ajay Jayant Kirtane, Rachel M. Easterwood et al. · JACC: Cardiovascular Interventions Open access 27 Jan 2021 61
20 A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease Iris Dotan, Daniel Rachmilewitz, Stefan Schreiber et al. · Gut 13 May 2010 56
21 Prevalence and Clinical Impact of Tissue Protrusion After Stent Implantation Fuyu Qiu, Gary S. Mintz, Bernhard Witzenbichler et al. · JACC: Cardiovascular Interventions Open access Jul 2016 54
22 Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes Diana Trofimovitch, Steven J. Baumrucker · American Journal of Hospice and Palliative Medicine® 27 Mar 2019 52
23 Comparison of Plaque Characteristics in Narrowings With ST-Elevation Myocardial Infarction (STEMI), Non-STEMI/Unstable Angina Pectoris and Stable Coronary Artery Disease (from the ADAPT-DES IVUS Substudy) Liang Dong, Gary S. Mintz, Bernhard Witzenbichler et al. · The American Journal of Cardiology 14 Jan 2015 52
24 Hypertension in diabetes and the risk of cardiovascular disease Nirmal T. Sunkara, Chowdhury H. Ahsan · Cardiovascular Endocrinology Open access 15 Feb 2017 48
25 Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study Gennaro Giustino et al. · The American Journal of Cardiology 6 Apr 2016 47
26 B-type Natriuretic Peptide and Risk of Contrast-Induced Acute Kidney Injury in Acute ST-Segment–Elevation Myocardial Infarction Rudolf Járai, George Dangas, Kurt Huber et al. · Circulation Cardiovascular Interventions Open access 29 Nov 2012 47
27 Evaluation of intracoronary hyperoxemic oxygen therapy in acute anterior myocardial infarction: The IC‐HOT study Shukri W. David, ZUBAIR AHMED KHAN, Nainesh C. Patel et al. · Catheterization and Cardiovascular Interventions 28 Sep 2018 46
28 American Dietetic Association: Standards of practice in nutrition care and updated standards of professional performance Kessey J. Kieselhorst, Janet J. Skates, Ellen Pritchett · Journal of the American Dietetic Association 31 Mar 2005 46
29 Phase II trial of R‐ CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601 Brian G. Till, Hongli Li, Steven H. Bernstein et al. · British Journal of Haematology Open access 22 Oct 2015 45
30 Selection of monitoring techniques for a carbon storage and enhanced coalbed methane recovery pilot test in the Central Appalachian Basin Ellen S. Gilliland, Nino Ripepi, Matthew S. Conrad et al. · International Journal of Coal Geology 16 Jul 2013 45
31 Prophylactic Left Atrial Appendage Exclusion in Cardiac Surgery Patients With Elevated CHA 2 DS 2 -VASc Score: Results of the Randomized ATLAS Trial Marc Gerdisch, Harvey Edward Garrett, Mubashir A. Mumtaz et al. · Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery Nov 2022 43
32 Predictors and Long‐Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug‐Eluting Stents (ADAPT‐DES) Intravascular Ultrasound Substudy Bin Wang, Gary S. Mintz, Bernhard Witzenbichler et al. · Journal of the American Heart Association Open access Dec 2016 43
33 The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention Sorin J. Brener, Ajay Jayant Kirtane, Thomas Stuckey et al. · JACC: Cardiovascular Interventions Open access Jul 2016 42
34 Sources of Hospital Variation in Short-Term Readmission Rates After Percutaneous Coronary Intervention Robert W. Yeh, Kenneth Rosenfield, Katya Zelevinsky et al. · Circulation Cardiovascular Interventions 22 Mar 2012 42
35 Cognitive and social-emotional changes associated with mesial orbitofrontal damage: Assessment and implications for treatment Kristie J. Nies · Neurocase Jul 1999 41
36 EEG evidence of more “intense” seizure activity with bilateral ECT Andrew D. Krystal, Richard D. Weiner, C. Edward Coffey et al. · Biological Psychiatry Mar 1992 40
37 Intravenous glomus tumor of the forearm Paul B. Googe, William C. Griffin · Journal of Cutaneous Pathology Aug 1993 38
38 Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents Thomas Stuckey, Ajay Jayant Kirtane, Bruce R. Brodie et al. · JACC: Cardiovascular Interventions Open access Aug 2017 37
39 Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention? Ajay Jayant Kirtane, Puja B. Parikh, Thomas Stuckey et al. · JACC: Cardiovascular Interventions Open access Dec 2015 35
40 Aromatase inhibitor–associated musculoskeletal pain: An overview of pathophysiology and treatment modalities Nelly Grigorian, Steven J. Baumrucker · SAGE Open Medicine Open access 2022 34
41 Perioperative Outcomes From the Prospective Multicenter Least Invasive Fast-Track EVAR (LIFE) Registry Zvonimir Krajcer, Venkatesh G. Ramaiah, Esteban A. Henao et al. · Journal of Endovascular Therapy Open access 18 Dec 2017 34
42 Experience and Outcomes With Carotid Artery Stenting Mehdi H. Shishehbor, Sridhar Venkatachalam, William A. Gray et al. · JACC: Cardiovascular Interventions Open access 15 Oct 2014 33
43 Microbial Numbers, Rumen Fermentation, and Nitrogen Utilization of Steers Fed Wet or Dried Brewers’ Grains John A. Rogers, Harry Russel Conrad, B. A. Dehority et al. · Journal of Dairy Science Open access Mar 1986 32
44 Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Vascular Closure Device During Percutaneous EVAR and TEVAR Procedures Zvonimir Krajcer, David Alexander Wood, Neil E. Strickman et al. · Journal of Endovascular Therapy 20 Mar 2020 31
45 One‐year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC‐HOT study Shmuel Chen, Shukri W. David, ZUBAIR AHMED KHAN et al. · Catheterization and Cardiovascular Interventions Open access 10 Jul 2020 30
46 The enigmatic immunoglobulin G4-related disease and its varied cardiovascular manifestations Aamina Shakir, Yurong Yang Wheeler, Guha A. Krishnaswamy · Heart 19 Jan 2021 29
47 Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention Björn Redfors, Ajay Jayant Kirtane, Mengdan Liu et al. · JACC: Cardiovascular Interventions Open access Apr 2022 28
48 Intracardiac ablation for atrioventricular nodal reentry tachycardia using a 6 mm distal electrode cryoablation catheter: Prospective, multicenter, North American study (ICY‐AVNRT STUDY) PETER J. WELLS, Marc Dubuc, George Joseph Klein et al. · Journal of Cardiovascular Electrophysiology Open access 17 Oct 2017 27
49 Age-related effects of smoking on culprit lesion plaque vulnerability as assessed by grayscale and virtual histology–intravascular ultrasound Soo-Jin Kang, Gary S. Mintz, Bernhard Witzenbichler et al. · Coronary Artery Disease 28 May 2015 27
50 Acute and 30-Day Safety and Effectiveness Evaluation of Eximo Medical's B-Laser™, a Novel Atherectomy Device, in Subjects Affected With Infrainguinal Peripheral Arterial Disease: Results of the EX-PAD-03 Trial Nicolas W. Shammas, Pradeep Chandra, Marianne Brodmann et al. · Cardiovascular revascularization medicine 29 Nov 2018 26

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.